Today the European Research Council (ERC) has announced the “Proof of Concept” awards for 50 European projects.
The Spanish Society of Neurology estimates that 600,000 people are affected by Alzheimer’s disease in this country.
On Monday 15 September, IRB Barcelona will be opening the registration for its third “Crazy About
From 24 to 26 September, IRB Barcelona’s Innovation Office will move to Santiago de Compostela to participate in the Biospain Fair, the main biotech meeting in Southern Europe and 5th in the world
To mark World Alzheimer's Day on 21 September, the newspaper ARA publishes an article about research trends into Alzheimer's disease. The article includes mention of the project led by Patrick Aloy on AD and funded by an ERC Consolidator Grant.
Joan J. Guinovart publishes an article in El País about the contributions of Emilio Botín, president of Bank of Santader who recently died at the age of 79, to the advancement of the science in Spain.
Feature article published in the Spanish science news website Excelenciencia about the IRB Barcelona initiatives to bring closer the science to the society. The aim behind the new approaches included in the article are to inform and attracting new donations.
«Our study highlights the complexity of p38 functions, both in cancer and in the maintenance of normal tissues. It shows why an inhibitor of this molecule could effectively have undesirable side effects. But these do not exclude it from being a target against cancer.»
More on this news here.
«Controlling a biological process from outside is the future of chemistry and opens up promising roads for advancements in pharmacological research.»
More info on this news here.
«98% of the potential therapeutic molecules against diseases of the central nervous system cannot cross the blood-brain barrier. We develop peptides with the capacity to open the doors of the barrier and act as shuttles when attached to a therapeutic molecule.»
Felice Alessio Bava
ex PhD student in the Translational Control of Cell Cycle and Differentiation Lab
«We suspected that CPEB1, a protein involved in regulating mRNA translation in the cytoplasm, might also be active in the nucleus and play a role in controlling pre-mRNA processing. We discovered that it affects the alternative generation in the mature mRNA of the 3'-UTR, regions where most of the elements regulating translation in time and space are located.»
More info about this news here.
Quick facts about IRB
IRB Barcelona is home to nearly 450 research, technical and support staff from 35 countries who share the common goal of contributing to the advancement of the biomedical sciences through investigator–driven research, and improving quality of life by applying advances in this field.
The convergence of biology, chemistry, and structural and computational biology is unique at IRB Barcelona and opens a strategic window to gain insight into basic molecular processes in health and disease.
Research is conducted by 23 groups organized into 5 interdisciplinary programmes. Each programme includes a diverse faculty of researchers with overlapping scientific interests. The research areas have been structured to be highly interactive, fostering multidisciplinarity by combining modern molecular biology, classical genetics, biochemistry, structural biology, bioinformatics, systems biology, advanced microscopy, and genomic and proteomic approaches.
IRB Barcelona is housed within the Barcelona Science Park on the University of Barcelona Pedralbes Campus. It is an integral part of the ‘Bioregion of Catalonia’, a rich landscape of research centres of excellence, universities, science parks, hospitals, scientific infrastructures and pharmaceutical companies, all with a focus on the life sciences. It is a member of the CERCA network of government research centres.